Stock listing
China National Medicines Corporation Ltd. Class A
Selected listing: 600511 · SSE · CNY · CN
China National Medicines Corporation Ltd. Class A (Shanghai:600511), Health Technology. Latest release Sep 24, 2026: "China National Medicines Corporation…
- Ticker
- Shanghai:600511
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About China National Medicines Corporation Ltd. Class A
The company is involved in the distribution and manufacturing of pharmaceutical products and healthcare services. As a public entity, it is subject to regulatory oversight and reporting requirements in China.
Latest news from China National Medicines Corporation Ltd. Class A
"China National Medicines Corporation Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 23, 2026
"China National Medicines Corporation Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
September 4, 2026
"China National Medicines Corporation Ltd."Announcement on Resolutions of the 41st Meeting of the 8th Board of Directors
August 19, 2026
"China National Medicines Corporation Ltd."Announcement on Opening of a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing of a Regulatory Agreement
June 30, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 18, 2026
All China National Medicines Corporation Ltd. Class A news →
Research China National Medicines Corporation Ltd. Class A
China National Medicines Corporation Ltd. Class A company profile
View the public company page for China National Medicines Corporation Ltd. Class A on 6ix.
China National Medicines Corporation Ltd. Class A news
Read company news and market updates connected to China National Medicines Corporation Ltd. Class A.
China National Medicines Corporation Ltd. Class A investor events
Find investor webinars, events, and replay context for China National Medicines Corporation Ltd. Class A.